Search Results for 'p-15l peptide enhanced bone graft'
-
Biologics
Cerapedics Expands its Headquarters
Company adds 10,000 square feet and doubles employee headcount at Denver metropolitan base.Cerapedics 08.29.19
-
Biologics
Cerapedics Appoints Vice President of Clinical and Market Development
New hire most recently served as director of Market Development for Spinal Kinetics, an Orthofix Company.PR Newswire 06.25.19
-
Biologics
Cerapedics Enrolls First Patients in IDE Clinical Trial of P-15L Bone Graft for TLIF Surgery
Proprietary synthetic small peptide technology is being evaluated in U.S. patients with degenerative disk disease.Cerapedics 07.30.18
-
Biologics
Cerapedics Receives FDA IDE Approval to Initiate Study of P-15L Bone Graft for TLIF Surgery
Pivotal study to evaluate next-generation synthetic small peptide technology compared to autograft in spine surgery.Cerapedics 03.16.18
